We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBIO icon
12376
PUT
Fortress Biotech
FBIO
$97.7M
$16K ﹤0.01%
1,307
-4,153
-76% -$61.5K
URG
12377
Ur-Energy
URG
$537M
$16K ﹤0.01%
14,780
-15,102
-51% -$20.2K
QNTM
12378
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$24.4M
$16K ﹤0.01%
+317
New +$19K
VEV
12379
DELISTED
Vicinity Motor Corp. Common Stock
VEV
$16K ﹤0.01%
+12,073
New +$21.1K
LMDXW
12380
DELISTED
LumiraDx Limited Warrant
LMDXW
$16K ﹤0.01%
18,170
-400
-2% -$346
YVR
12381
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
$16K ﹤0.01%
+10,498
New +$21.1K
LABP
12382
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$16K ﹤0.01%
+2,112
New +$19.2K
SEAC
12383
PUT
DELISTED
Seachange International Inc
SEAC
$16K ﹤0.01%
1,295
-700
-35% -$12.2K
AXU
12384
DELISTED
Alexco Resource Corp
AXU
$16K ﹤0.01%
40,058
-96,464
-71% -$93.8K
AIHS icon
12385
Senmiao Technology Ltd
AIHS
$23.9M
$15K ﹤0.01%
1,477
+969
+191% +$11.2K
AKTX
12386
Akari Therapeutics
AKTX
$13.2M
$15K ﹤0.01%
+19
New +$16.8K
AMST icon
12387
Amesite
AMST
$6.37M
$15K ﹤0.01%
+2,685
New +$18.6K
CREX icon
12388
Creative Realities
CREX
$43M
$15K ﹤0.01%
+8,271
New +$17.3K
HIPO icon
12389
CALL
Hippo Holdings
HIPO
$872M
$15K ﹤0.01%
700
-4,192
-86% -$155K
JZXN icon
12390
Jiuzi Holdings
JZXN
$713K
$15K ﹤0.01%
2
KRKR
12391
36Kr Holdings
KRKR
$6.07M
$15K ﹤0.01%
744
-162
-18% -$3.01K
KXIN icon
12392
CALL
Kaixin Holdings
KXIN
$8.43M
0
LGMK
12393
PUT
DELISTED
LogicMark
LGMK
$15K ﹤0.01%
27
-85
-76% -$63.3K
LODE icon
12394
PUT
Comstock
LODE
$263M
$15K ﹤0.01%
2,380
+440
+23% +$4.39K
NCMI icon
12395
CALL
National CineMedia
NCMI
$269M
$15K ﹤0.01%
+1,620
New +$27.4K
QMCO icon
12396
CALL
Quantum Corp
QMCO
$1.03B
$15K ﹤0.01%
+520
New +$19.7K
SLDB icon
12397
CALL
Solid Biosciences
SLDB
$986M
$15K ﹤0.01%
1,647
+140
+9% +$1.46K
SDSTW
12398
Stardust Power Inc Warrant
SDSTW
$5.67M
$15K ﹤0.01%
82,786
-47,080
-36% -$13.5K
IVF
12399
INVO Fertility Inc
IVF
$1.74M
$15K ﹤0.01%
1
CFFSW
12400
DELISTED
CF Acquisition Corp. VII Warrant
CFFSW
$15K ﹤0.01%
95,870
-185,714
-66% -$60.2K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.